Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02137837
Title S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Recruitment Terminated
Gender female
Phase Phase III
Variant Requirements No
Sponsors Southwest Oncology Group
Age Groups: adult
Covered Countries USA

No variant requirements are available.